Takuya Osada

Duke Medical Center — United States

Immunology and Microbiology · Life Sciences

45h-index6.8kcitations276works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(106), Cancer Immunotherapy and Biomarkers(76), CAR-T cell therapy research(54), Monoclonal and Polyclonal Antibodies Research(49), HER2/EGFR in Cancer Research(34)

Publications276 total

A Precision Ultrasound-Localized Sonoporation-Equipment (PULSE) Enabling Intratumoral Delivery for Cancer Immunotherapy
2025· 1 citedOpen Access
Enfortumab Vedotin-Induced Febrile Neutropenia and Hyperglycemia Successfully Treated with Multidisciplinary Treatment Including Continuous Hemodialysis Filtration and Insulin Injection in a Patient with Chemo-Resistant Metastatic Urothelial Carcinoma: A Case Report
Case Reports in Oncology·2024· 5 citedOpen Access
Abstract 1415: Reduction in photoimmunotherapy-induced edema with COX-2 inhibition: Combatting clinically relevant adverse events without compromising efficacy
Cancer Research·2024· 2 cited
The use of histotripsy as intratumoral immunotherapy beyond tissue ablation—the rationale for exploring the immune effects of histotripsy
International Journal of Hyperthermia·2023· 12 citedOpen Access
Ultrasound Enhanced Perfusion and Drug Penetration for Intratumoral Immunotherapy Using a Needle Ultrasound Transducer - a Phantom Study
2023· 3 cited
Supplementary Materials and Methods from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Materials and Methods from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Figure 1 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Data from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Table 2 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Table 2 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Table 1 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Table 1 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Figure Legends 1-2 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Table 3 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Table 4 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Figure Legends 1-2 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Figure 2 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Figure 1 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
Supplementary Table 4 from Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2023Open Access
page 1 of 14Next →

Frequent Co-authors

H. Kim Lyerly(36), Michael A. Morse(28), Timothy M. Clay(20), Amy Hobeika(18), Hirokazu Nagawa(11), Donna Niedzwiecki(8), David S. Hsu(8), Nelson H. Tsuno(8), Zachary C. Hartman(8), Neil L. Spector(7), Joji Kitayama(7), Kimberly Blackwell(7), Timothy Clay(5), Wei Chen(5), Xiaoyi Yang(5), Gayathri R. Devi(5), Tetsuichiro Muto(5), Xiao Yang(4), Bryan M. Clary(4), Eiji Sunami(4)